HEADER OXIDOREDUCTASE/INHIBITOR 11-MAR-22 7U9U TITLE CRYSTAL STRUCTURE OF HUMAN D-AMINO ACID OXIDASE IN COMPLEX WITH TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: D-AMINO-ACID OXIDASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: DAAO,DAMOX,DAO; COMPND 5 EC: 1.4.3.3; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DAO, DAMOX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS FAD, FLAVOPROTEIN, OXIDOREDUCTASE, PEROXISOME, OXIDOREDUCTASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR R.J.SKENE,J.A.BELL REVDAT 2 18-OCT-23 7U9U 1 REMARK REVDAT 1 08-JUN-22 7U9U 0 JRNL AUTH H.TANG,K.JENSEN,E.HOUANG,F.M.MCROBB,S.BHAT,M.SVENSSON, JRNL AUTH 2 A.BOCHEVAROV,T.DAY,M.K.DAHLGREN,J.A.BELL,L.FRYE,R.J.SKENE, JRNL AUTH 3 J.H.LEWIS,J.D.OSBORNE,J.P.TIERNEY,J.A.GORDON,M.A.PALOMERO, JRNL AUTH 4 C.GALLATI,R.S.L.CHAPMAN,D.R.JONES,K.L.HIRST,M.SEPHTON, JRNL AUTH 5 A.CHAUHAN,A.SHARPE,P.TARDIA,E.A.DECHAUX,A.TAYLOR, JRNL AUTH 6 R.D.WADDELL,A.VALENTINE,H.B.JANSSENS,O.AZIZ,D.E.BLOOMFIELD, JRNL AUTH 7 S.LADHA,I.J.FRASER,J.M.ELLARD JRNL TITL DISCOVERY OF A NOVEL CLASS OF D-AMINO ACID OXIDASE JRNL TITL 2 INHIBITORS USING THE SCHRODINGER COMPUTATIONAL PLATFORM. JRNL REF J.MED.CHEM. V. 65 6775 2022 JRNL REFN ISSN 0022-2623 JRNL PMID 35482677 JRNL DOI 10.1021/ACS.JMEDCHEM.2C00118 REMARK 2 REMARK 2 RESOLUTION. 1.66 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PRIME-X REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.66 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 85711 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.235 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 4361 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.010 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.66 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.72 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 8571 REMARK 3 BIN R VALUE (WORKING SET) : 0.3860 REMARK 3 BIN FREE R VALUE : 0.4020 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 436 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.010 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5460 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 135 REMARK 3 SOLVENT ATOMS : 214 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7U9U COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-MAR-22. REMARK 100 THE DEPOSITION ID IS D_1000263808. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 09-SEP-19 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.4 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 85786 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.660 REMARK 200 RESOLUTION RANGE LOW (A) : 49.450 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.06100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.66 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 6.60 REMARK 200 R MERGE FOR SHELL (I) : 2.07400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2DU8 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1M SUCCINATE PH 7.0, 0.1M TRIS, PH REMARK 280 8.5, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 61.40300 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.70150 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 61.40300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.70150 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -39.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG A 341 REMARK 465 MET A 342 REMARK 465 PRO A 343 REMARK 465 PRO A 344 REMARK 465 SER A 345 REMARK 465 HIS A 346 REMARK 465 LEU A 347 REMARK 465 SER B 340 REMARK 465 ARG B 341 REMARK 465 MET B 342 REMARK 465 PRO B 343 REMARK 465 PRO B 344 REMARK 465 SER B 345 REMARK 465 HIS B 346 REMARK 465 LEU B 347 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PRO A 82 H2 HOH A 501 1.55 REMARK 500 O TYR A 128 H2 HOH A 502 1.59 REMARK 500 O TYR B 128 H1 HOH B 502 1.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 HIS A 80 CG HIS A 80 CD2 0.059 REMARK 500 HIS A 256 CG HIS A 256 CD2 0.059 REMARK 500 HIS B 80 CG HIS B 80 CD2 0.061 REMARK 500 HIS B 99 CG HIS B 99 CD2 0.058 REMARK 500 HIS B 256 CG HIS B 256 CD2 0.057 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 53 111.95 -164.20 REMARK 500 SER A 136 -157.91 -129.59 REMARK 500 CYS A 181 56.19 -119.52 REMARK 500 ASN A 225 48.16 -97.87 REMARK 500 LEU A 339 40.32 -95.11 REMARK 500 GLN B 28 74.84 -151.94 REMARK 500 GLN B 53 109.62 -167.20 REMARK 500 ASN B 83 1.88 -67.70 REMARK 500 TYR B 224 -6.08 79.66 REMARK 500 ARG B 297 47.84 -86.45 REMARK 500 THR B 298 51.43 -101.50 REMARK 500 SER B 301 52.21 81.39 REMARK 500 ASN B 302 99.83 -41.52 REMARK 500 ASN B 308 84.17 -150.50 REMARK 500 TYR B 314 23.41 -142.43 REMARK 500 LYS B 338 -133.27 -152.87 REMARK 500 REMARK 500 REMARK: NULL DBREF 7U9U A 1 347 UNP P14920 OXDA_HUMAN 1 347 DBREF 7U9U B 1 347 UNP P14920 OXDA_HUMAN 1 347 SEQRES 1 A 347 MET ARG VAL VAL VAL ILE GLY ALA GLY VAL ILE GLY LEU SEQRES 2 A 347 SER THR ALA LEU CYS ILE HIS GLU ARG TYR HIS SER VAL SEQRES 3 A 347 LEU GLN PRO LEU ASP ILE LYS VAL TYR ALA ASP ARG PHE SEQRES 4 A 347 THR PRO LEU THR THR THR ASP VAL ALA ALA GLY LEU TRP SEQRES 5 A 347 GLN PRO TYR LEU SER ASP PRO ASN ASN PRO GLN GLU ALA SEQRES 6 A 347 ASP TRP SER GLN GLN THR PHE ASP TYR LEU LEU SER HIS SEQRES 7 A 347 VAL HIS SER PRO ASN ALA GLU ASN LEU GLY LEU PHE LEU SEQRES 8 A 347 ILE SER GLY TYR ASN LEU PHE HIS GLU ALA ILE PRO ASP SEQRES 9 A 347 PRO SER TRP LYS ASP THR VAL LEU GLY PHE ARG LYS LEU SEQRES 10 A 347 THR PRO ARG GLU LEU ASP MET PHE PRO ASP TYR GLY TYR SEQRES 11 A 347 GLY TRP PHE HIS THR SER LEU ILE LEU GLU GLY LYS ASN SEQRES 12 A 347 TYR LEU GLN TRP LEU THR GLU ARG LEU THR GLU ARG GLY SEQRES 13 A 347 VAL LYS PHE PHE GLN ARG LYS VAL GLU SER PHE GLU GLU SEQRES 14 A 347 VAL ALA ARG GLU GLY ALA ASP VAL ILE VAL ASN CYS THR SEQRES 15 A 347 GLY VAL TRP ALA GLY ALA LEU GLN ARG ASP PRO LEU LEU SEQRES 16 A 347 GLN PRO GLY ARG GLY GLN ILE MET LYS VAL ASP ALA PRO SEQRES 17 A 347 TRP MET LYS HIS PHE ILE LEU THR HIS ASP PRO GLU ARG SEQRES 18 A 347 GLY ILE TYR ASN SER PRO TYR ILE ILE PRO GLY THR GLN SEQRES 19 A 347 THR VAL THR LEU GLY GLY ILE PHE GLN LEU GLY ASN TRP SEQRES 20 A 347 SER GLU LEU ASN ASN ILE GLN ASP HIS ASN THR ILE TRP SEQRES 21 A 347 GLU GLY CYS CYS ARG LEU GLU PRO THR LEU LYS ASN ALA SEQRES 22 A 347 ARG ILE ILE GLY GLU ARG THR GLY PHE ARG PRO VAL ARG SEQRES 23 A 347 PRO GLN ILE ARG LEU GLU ARG GLU GLN LEU ARG THR GLY SEQRES 24 A 347 PRO SER ASN THR GLU VAL ILE HIS ASN TYR GLY HIS GLY SEQRES 25 A 347 GLY TYR GLY LEU THR ILE HIS TRP GLY CYS ALA LEU GLU SEQRES 26 A 347 ALA ALA LYS LEU PHE GLY ARG ILE LEU GLU GLU LYS LYS SEQRES 27 A 347 LEU SER ARG MET PRO PRO SER HIS LEU SEQRES 1 B 347 MET ARG VAL VAL VAL ILE GLY ALA GLY VAL ILE GLY LEU SEQRES 2 B 347 SER THR ALA LEU CYS ILE HIS GLU ARG TYR HIS SER VAL SEQRES 3 B 347 LEU GLN PRO LEU ASP ILE LYS VAL TYR ALA ASP ARG PHE SEQRES 4 B 347 THR PRO LEU THR THR THR ASP VAL ALA ALA GLY LEU TRP SEQRES 5 B 347 GLN PRO TYR LEU SER ASP PRO ASN ASN PRO GLN GLU ALA SEQRES 6 B 347 ASP TRP SER GLN GLN THR PHE ASP TYR LEU LEU SER HIS SEQRES 7 B 347 VAL HIS SER PRO ASN ALA GLU ASN LEU GLY LEU PHE LEU SEQRES 8 B 347 ILE SER GLY TYR ASN LEU PHE HIS GLU ALA ILE PRO ASP SEQRES 9 B 347 PRO SER TRP LYS ASP THR VAL LEU GLY PHE ARG LYS LEU SEQRES 10 B 347 THR PRO ARG GLU LEU ASP MET PHE PRO ASP TYR GLY TYR SEQRES 11 B 347 GLY TRP PHE HIS THR SER LEU ILE LEU GLU GLY LYS ASN SEQRES 12 B 347 TYR LEU GLN TRP LEU THR GLU ARG LEU THR GLU ARG GLY SEQRES 13 B 347 VAL LYS PHE PHE GLN ARG LYS VAL GLU SER PHE GLU GLU SEQRES 14 B 347 VAL ALA ARG GLU GLY ALA ASP VAL ILE VAL ASN CYS THR SEQRES 15 B 347 GLY VAL TRP ALA GLY ALA LEU GLN ARG ASP PRO LEU LEU SEQRES 16 B 347 GLN PRO GLY ARG GLY GLN ILE MET LYS VAL ASP ALA PRO SEQRES 17 B 347 TRP MET LYS HIS PHE ILE LEU THR HIS ASP PRO GLU ARG SEQRES 18 B 347 GLY ILE TYR ASN SER PRO TYR ILE ILE PRO GLY THR GLN SEQRES 19 B 347 THR VAL THR LEU GLY GLY ILE PHE GLN LEU GLY ASN TRP SEQRES 20 B 347 SER GLU LEU ASN ASN ILE GLN ASP HIS ASN THR ILE TRP SEQRES 21 B 347 GLU GLY CYS CYS ARG LEU GLU PRO THR LEU LYS ASN ALA SEQRES 22 B 347 ARG ILE ILE GLY GLU ARG THR GLY PHE ARG PRO VAL ARG SEQRES 23 B 347 PRO GLN ILE ARG LEU GLU ARG GLU GLN LEU ARG THR GLY SEQRES 24 B 347 PRO SER ASN THR GLU VAL ILE HIS ASN TYR GLY HIS GLY SEQRES 25 B 347 GLY TYR GLY LEU THR ILE HIS TRP GLY CYS ALA LEU GLU SEQRES 26 B 347 ALA ALA LYS LEU PHE GLY ARG ILE LEU GLU GLU LYS LYS SEQRES 27 B 347 LEU SER ARG MET PRO PRO SER HIS LEU HET FAD A 401 85 HET BEZ A 402 14 HET FAD B 401 85 HET M89 B 402 29 HETNAM FAD FLAVIN-ADENINE DINUCLEOTIDE HETNAM BEZ BENZOIC ACID HETNAM M89 (3R)-3-(5,6-DIOXO-1,4,5,6-TETRAHYDROPYRAZIN-2-YL)-2,3- HETNAM 2 M89 DIHYDRO-1,4-BENZOXATHIINE-7-CARBONITRILE FORMUL 3 FAD 2(C27 H33 N9 O15 P2) FORMUL 4 BEZ C7 H6 O2 FORMUL 6 M89 C13 H9 N3 O3 S FORMUL 7 HOH *214(H2 O) HELIX 1 AA1 GLY A 9 HIS A 24 1 16 HELIX 2 AA2 THR A 43 ALA A 48 1 6 HELIX 3 AA3 PRO A 62 SER A 77 1 16 HELIX 4 AA4 ASN A 83 GLY A 88 1 6 HELIX 5 AA5 PRO A 105 THR A 110 5 6 HELIX 6 AA6 THR A 118 ASP A 123 1 6 HELIX 7 AA7 GLU A 140 ARG A 155 1 16 HELIX 8 AA8 SER A 166 GLU A 173 1 8 HELIX 9 AA9 THR A 182 LEU A 189 5 8 HELIX 10 AB1 ASP A 218 GLY A 222 5 5 HELIX 11 AB2 ASN A 252 GLU A 267 1 16 HELIX 12 AB3 PRO A 268 ALA A 273 5 6 HELIX 13 AB4 HIS A 311 GLY A 313 5 3 HELIX 14 AB5 TYR A 314 LEU A 339 1 26 HELIX 15 AB6 GLY B 9 HIS B 24 1 16 HELIX 16 AB7 THR B 44 ALA B 48 5 5 HELIX 17 AB8 PRO B 62 HIS B 78 1 17 HELIX 18 AB9 ASN B 83 GLY B 88 1 6 HELIX 19 AC1 PRO B 105 THR B 110 5 6 HELIX 20 AC2 THR B 118 ASP B 123 1 6 HELIX 21 AC3 GLU B 140 ARG B 155 1 16 HELIX 22 AC4 SER B 166 GLU B 173 1 8 HELIX 23 AC5 THR B 182 LEU B 189 5 8 HELIX 24 AC6 ASN B 252 GLU B 267 1 16 HELIX 25 AC7 PRO B 268 ALA B 273 5 6 HELIX 26 AC8 TYR B 314 LYS B 338 1 25 SHEET 1 AA1 6 LYS A 158 GLN A 161 0 SHEET 2 AA1 6 ASP A 31 ALA A 36 1 N VAL A 34 O LYS A 158 SHEET 3 AA1 6 ARG A 2 ILE A 6 1 N VAL A 3 O ASP A 31 SHEET 4 AA1 6 VAL A 177 ASN A 180 1 O VAL A 179 N ILE A 6 SHEET 5 AA1 6 SER A 301 TYR A 309 1 O ILE A 306 N ASN A 180 SHEET 6 AA1 6 ARG A 290 THR A 298 -1 N THR A 298 O SER A 301 SHEET 1 AA2 8 LEU A 112 LYS A 116 0 SHEET 2 AA2 8 TYR A 130 LEU A 139 -1 O THR A 135 N LEU A 112 SHEET 3 AA2 8 LEU A 89 PHE A 98 -1 N ILE A 92 O SER A 136 SHEET 4 AA2 8 PHE A 213 THR A 216 1 O LEU A 215 N LEU A 97 SHEET 5 AA2 8 TYR A 228 PRO A 231 -1 O ILE A 229 N ILE A 214 SHEET 6 AA2 8 VAL A 236 GLY A 239 -1 O THR A 237 N ILE A 230 SHEET 7 AA2 8 GLN A 196 ASP A 206 -1 N MET A 203 O LEU A 238 SHEET 8 AA2 8 GLN A 243 LEU A 244 -1 O GLN A 243 N ARG A 199 SHEET 1 AA3 8 LEU A 112 LYS A 116 0 SHEET 2 AA3 8 TYR A 130 LEU A 139 -1 O THR A 135 N LEU A 112 SHEET 3 AA3 8 LEU A 89 PHE A 98 -1 N ILE A 92 O SER A 136 SHEET 4 AA3 8 PHE A 213 THR A 216 1 O LEU A 215 N LEU A 97 SHEET 5 AA3 8 TYR A 228 PRO A 231 -1 O ILE A 229 N ILE A 214 SHEET 6 AA3 8 VAL A 236 GLY A 239 -1 O THR A 237 N ILE A 230 SHEET 7 AA3 8 GLN A 196 ASP A 206 -1 N MET A 203 O LEU A 238 SHEET 8 AA3 8 ARG A 274 VAL A 285 -1 O GLY A 281 N GLY A 200 SHEET 1 AA4 6 LYS B 158 GLN B 161 0 SHEET 2 AA4 6 ASP B 31 ALA B 36 1 N VAL B 34 O LYS B 158 SHEET 3 AA4 6 ARG B 2 ILE B 6 1 N VAL B 5 O TYR B 35 SHEET 4 AA4 6 VAL B 177 ASN B 180 1 O VAL B 179 N ILE B 6 SHEET 5 AA4 6 THR B 303 TYR B 309 1 O ILE B 306 N ILE B 178 SHEET 6 AA4 6 ARG B 290 LEU B 296 -1 N GLU B 294 O VAL B 305 SHEET 1 AA5 8 LEU B 112 LYS B 116 0 SHEET 2 AA5 8 TYR B 130 LEU B 139 -1 O THR B 135 N LEU B 112 SHEET 3 AA5 8 LEU B 89 PHE B 98 -1 N ILE B 92 O SER B 136 SHEET 4 AA5 8 HIS B 212 THR B 216 1 O LEU B 215 N LEU B 97 SHEET 5 AA5 8 TYR B 228 PRO B 231 -1 O ILE B 229 N ILE B 214 SHEET 6 AA5 8 VAL B 236 GLY B 239 -1 O THR B 237 N ILE B 230 SHEET 7 AA5 8 GLN B 196 ASP B 206 -1 N MET B 203 O LEU B 238 SHEET 8 AA5 8 GLN B 243 LEU B 244 -1 O GLN B 243 N ARG B 199 SHEET 1 AA6 8 LEU B 112 LYS B 116 0 SHEET 2 AA6 8 TYR B 130 LEU B 139 -1 O THR B 135 N LEU B 112 SHEET 3 AA6 8 LEU B 89 PHE B 98 -1 N ILE B 92 O SER B 136 SHEET 4 AA6 8 HIS B 212 THR B 216 1 O LEU B 215 N LEU B 97 SHEET 5 AA6 8 TYR B 228 PRO B 231 -1 O ILE B 229 N ILE B 214 SHEET 6 AA6 8 VAL B 236 GLY B 239 -1 O THR B 237 N ILE B 230 SHEET 7 AA6 8 GLN B 196 ASP B 206 -1 N MET B 203 O LEU B 238 SHEET 8 AA6 8 ARG B 274 VAL B 285 -1 O GLY B 277 N LYS B 204 CISPEP 1 THR A 40 PRO A 41 0 9.11 CISPEP 2 THR B 40 PRO B 41 0 4.51 CRYST1 122.806 73.403 79.799 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008143 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013623 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012531 0.00000